Inhibitory effects of melatonin on the development of 17-β-estradiol induced prolactinoma in relation to plasma prolactin and peroxidative lipid contents
- Author:
- No author available
- Journal Title:
- ACTA PHYSIOLOGICA SINICA
- Issue:
- 3
- DOI:
- 10.3321/j.issn:0371-0874.2001.03.001
- Key Word:
- 褪黑素;垂体催乳素瘤;17-β雌二醇;催乳素;过氧化脂质
Abstract： 雄性大鼠皮下埋置17-β雌二醇(17-β-estradiol, E2)药泵诱发垂体催乳素PRL)瘤,并每日皮下注射褪黑素(melatonin, MLT)观察MLT对E2诱发PRL瘤生长的影响.另外,采用放免法和紫外分光光度法测定大鼠血浆PRL和过氧化脂质(peroxidative lipid, PL)浓度,观察PRL瘤重量与大鼠血浆浓度间的相关关系.实验结果显示,在对照组、0.05、0.25、0.50、1.00和2.00 mg MLT组,PRL瘤重量分别为115.0±71.0、85.2±41.0、58.9±24.1、72.7±23.6、79.3±56.1、74.5±46.8 mg;血浆PRL浓度分别为493.46±33.3、373.78±26.5、125.13±13.3、201.79±11.2、418.88±41.3、281.94±36.4 ng/ml;血浆PL水平分别为1.21±0.23、0.89±0.32、0.92±0.27、0.64±0.24、0.41±0.14、0.43±0.21 △D233/ml.相关性分析表明,PRL瘤重量与血浆PRL浓度间的相关系数为0.8738(P＜0.05),与血浆PL水平间的相关系数为0.5550(P＞0.05),血浆PRL浓度与血浆PL水平间的相关系数为0.2141(P＞0.05).该结果提示,(1)0.25(P＜0.01)、0.50(P＜0.05)mg MLT能有效抑制E2诱致的PRL瘤生长和PRL分泌,所有剂量的MLT均能抑制血浆PL的形成;(2)PRL瘤重量与血浆PRL浓度间呈正相关关系,PRL瘤重量与血浆PL水平间、以及血浆PRL浓度与血浆PL水平间均无相关关系.因此,我们认为,MLT抑制E2诱致的PRL瘤生长可能与MLT抑制PRL表达性分泌有关,但与MLT抗氧化作用无关.
- [1]许荣琨,郭传海,黄曼影,等.INDUCTION OF RAT PROLACTINOMA BY β-ESTRADIOL AND ITS RELATION TO EXPRESSION OF C-MYC ONCOGENE[J].1995,(1).
- [2]G. A. Lincoln,K.-I. Maeda.Effects of placing micro-implants of melatonin in the mediobasal hypothalamus and preoptic area on the secretion of prolactin and β-endorphin in rams[J].1992,134(3).
- [3]Lemus-Wilson A,Kelly PA,Blask DE.Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture[J].1995.
- [4]C, Viguié,J, Thibault,J C, Thiéry,etc.Characterization of the short day-induced decrease in median eminence tyrosine hydroxylase activity in the ewe: temporal relationship to the changes in luteinizing hormone and prolactin secretion and short day-like effect of melatonin.[J].1997,138.
- [5]A, Panzer,M, Viljoen.The validity of melatonin as an oncostatic agent.[J].1997,22(4).
- [6]Molis T M,Spriggs L L,Hill S M.Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells.[J].1994.
- [7]Uddin M.,Alexiuk NAM.,Vriend J..Melatonin Increases the in Situ Activity of Tyrosine Hydroxylase in the Mediobasal Hypothalamus of Male Syrian Hamsters[J].1996,59(8).
- [8]D.E.Blask,J.L.Nodelman,C.A.Leadem.Preliminary evidence that a dopamine receptor antagonist blocks the prolactin-inhibitory effects of melatonin in anosmic male rats[J].1980,36(8).
- [9]C A, Leadem,D E, Blask.Evidence for an inhibitory influence of the pineal on prolactin in the female rat.[J].1981,33.
- [10]Vanecek J,Klein DC.Mechanism of melatonin signal transduction in the neonatal rat pituitary.[J].1995,27(3).
- [11]D. E. Stack,P. D. Devanesan,E. L. Cavalieri.Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators[J].1997,94(20).
- [12]Ebisawa.Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores.[J].1994,91.